Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-09-27Clinical Trial Update: Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection [NA]
This document reports a clinical trial update evaluating the best timing for administering plerixafor during autologous hematopoietic stem c…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia [Phase 2]
Phase 2 trial evaluating a combination of bortezomib, liposomal doxorubicin, and dexamethasone for plasma cell leukemia, with multiple myelo…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM) [Phase 2]
Phase 2 clinical trial update evaluating early response-adapted intensification of induction chemotherapy in newly diagnosed multiple myelom…
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: GEM05 for Patients With Multiple Myeloma More Than 65 Years Old [Phase 3]
GEM05's Phase 3 trial in patients with multiple myeloma aged over 65 has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma [Phase 4]
Phase 4 trial update showing completion of two bortezomib-based regimens (VAMP/TaCyDex and V-MP/TaCyDex) in refractory or relapsed multiple …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma [Phase 2]
Phase 2 trial evaluating bortezomib (Velcade) given after allogeneic peripheral blood stem cell transplantation in patients with multiple my…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating high-dose density therapy in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-01Clinical Trial Update: Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma [NA]
A completed clinical trial evaluated whether ice chips or saline mouth rinse can reduce or prevent mucositis in multiple myeloma patients un…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 clinical trial update evaluating the combination of antithymocyte globulin and sirolimus in patients with relapsed multiple myelom…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Pseudohyponatremia of Multiple Myeloma is True Hyponatremia
A clinical trial update concludes that hyponatremia observed in patients with multiple myeloma is true hyponatremia rather than pseudohypona…
-
CLINICAL_TRIALS research · 2011-08-25Clinical Trial Update: Clinical Evaluation of the Serum Free Light Chain Analysis
This entry notes a clinical trial evaluating serum free light chain analysis as a diagnostic tool in multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2 [Phase 3]
An update on a Phase 3 study of Total Therapy 2 in multiple myeloma patients who relapse or progress after autologous transplantation; the t…
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
Phase 2 trial evaluating lenalidomide, cyclophosphamide, and dexamethasone in patients with systemic amyloidosis has completed with results …
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma [NA]
A completed clinical trial evaluating coagulation-related effects of Velcade (bortezomib) in relapsed or refractory multiple myeloma; result…
-
CLINICAL_TRIALS research · 2011-08-12Clinical Trial Update: A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma [Phase 1, Phase 2]
Clinical trial update on a Phase I/II study evaluating romidepsin in combination with bortezomib for relapsed multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating the combination of lenalidomide, bendamustine, and prednisone (RBP…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 trial evaluating AVN-944 in patients with advanced hematologic malignancies has completed, spanning acute and chronic leukemia, mu…
-
CLINICAL_TRIALS research · 2011-08-04Clinical Trial Update: Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a chemoprevention therapy for individuals at high risk of developing multiple myeloma; the study status is…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation [Phase 3]
A Phase 3 trial comparing DTPACE followed by tandem autologous transplant with high-dose melphalan versus a MEL/DT-PACE hybrid regimen with …
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: PS-341 in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 study of PS-341 (bortezomib) in patients with advanced cancer has completed, including leukemia and lymphoma cohorts among the liste…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer [Phase 2]
This is a Phase II clinical trial evaluating an umbilical cord blood transplant using fludarabine, melphalan, and anti-thymocyte globulin in…
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a three-drug regimen of lenalidomide, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma; resu…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma [Phase 2]
A Phase 2 trial assessed higher-frequency dosing of zoledronic acid in patients with multiple myeloma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated sirolimus, tacrolimus, and methotrexate to prevent acute graft-versus-host disease in patients with he…
-
FDA approval · 2011-07-14FDA Approved: MELPHALAN HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Melphalan Hydrochloride from Mylan Institutional LLC, authorizing the generic drug's continued m…